Cocrystal Pharma appointed James Sapirstein as Chief Executive Officer effective immediately, replacing co-CEOs Sam Lee and Jim Martin. Sapirstein brings 23 product launches and extensive antiviral development experience from prior roles at Contravir, Tobira, and Gilead Sciences.